NASDAQ:TRHC - Tabula Rasa HealthCare Stock Price, News, & Analysis

$49.14
+0.87 (+1.80 %)
(As of 06/19/2019 06:48 AM ET)
Today's Range
$47.46
Now: $49.14
$49.34
50-Day Range
$41.18
MA: $47.06
$55.29
52-Week Range
$40.86
Now: $49.14
$91.16
Volume403,807 shs
Average Volume387,391 shs
Market Capitalization$1.08 billion
P/E Ratio144.53
Dividend YieldN/A
Beta1.68
Tabula Rasa HealthCare, Inc operates as a healthcare technology company in the field of medication safety in the United States. The company's proprietary Medication Risk Mitigation Matrix delivers a multi-drug review, which identifies medication-related risks. Its cloud-based software applications include EireneRx, a medication decision-support and e-prescribing platform to access patients' medication-related information; and MedWise that provides medication decision support components for clients seeking to manage their medication risk and improve medication outcomes, and patient relationships by enhancing their existing systems. Read More…

Industry, Sector and Symbol

Industry Business services, not elsewhere classified
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:TRHC
CUSIPN/A
Phone866-648-2767

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$204.27 million
Cash Flow$1.2952 per share
Book Value$6.79 per share

Profitability

Net Income$-47,270,000.00

Miscellaneous

Employees952
Market Cap$1.08 billion
Next Earnings Date8/6/2019 (Estimated)
OptionableOptionable

Receive TRHC News and Ratings via Email

Sign-up to receive the latest news and ratings for TRHC and its competitors with MarketBeat's FREE daily newsletter.

Tabula Rasa HealthCare (NASDAQ:TRHC) Frequently Asked Questions

What is Tabula Rasa HealthCare's stock symbol?

Tabula Rasa HealthCare trades on the NASDAQ under the ticker symbol "TRHC."

How were Tabula Rasa HealthCare's earnings last quarter?

Tabula Rasa HealthCare Inc (NASDAQ:TRHC) issued its quarterly earnings results on Wednesday, May, 8th. The company reported ($0.14) earnings per share for the quarter, hitting the Thomson Reuters' consensus estimate of ($0.14). The company had revenue of $60.96 million for the quarter, compared to the consensus estimate of $59.24 million. Tabula Rasa HealthCare had a negative net margin of 18.15% and a positive return on equity of 4.22%. View Tabula Rasa HealthCare's Earnings History.

When is Tabula Rasa HealthCare's next earnings date?

Tabula Rasa HealthCare is scheduled to release their next quarterly earnings announcement on Tuesday, August 6th 2019. View Earnings Estimates for Tabula Rasa HealthCare.

What price target have analysts set for TRHC?

10 equities research analysts have issued twelve-month price objectives for Tabula Rasa HealthCare's shares. Their predictions range from $58.00 to $100.00. On average, they anticipate Tabula Rasa HealthCare's stock price to reach $84.2330 in the next twelve months. This suggests a possible upside of 71.4% from the stock's current price. View Analyst Price Targets for Tabula Rasa HealthCare.

What is the consensus analysts' recommendation for Tabula Rasa HealthCare?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Tabula Rasa HealthCare in the last year. There are currently 2 hold ratings, 7 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Tabula Rasa HealthCare.

What are Wall Street analysts saying about Tabula Rasa HealthCare stock?

Here are some recent quotes from research analysts about Tabula Rasa HealthCare stock:
  • 1. According to Zacks Investment Research, "Tabula Rasa HealthCare, Inc. is a provider of patient-specific, data-driven technology and solutions which enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk. The company's cloud-based software applications including EireneRx and MedWise Advisor which provide solutions to payers, providers and other healthcare organizations. Tabula Rasa HealthCare, Inc. is based in NJ, United States. " (6/15/2019)
  • 2. Cantor Fitzgerald analysts commented, ". We reiterate our Overweight rating on TRHC shares and maintain our 12-month price target at $99. Rasa reported 1Q19 results, which appeared to be strong. We note that the company posted strong organic growth of 19%. Adjusted EBITDA was above our estimate and the company reaffirmed its 2019 guidance for revenue and adjusted EBITDA. Our EPS estimates moved lower to reflect the higher interest expense given the 1Q19 convert. While the company has executed in the short term, we suspect that investors are more concerned about the number of acquisitions the company has completed in the last two years and its integration efforts." (5/13/2019)

Has Tabula Rasa HealthCare been receiving favorable news coverage?

News coverage about TRHC stock has trended somewhat positive on Wednesday, according to InfoTrie. InfoTrie scores the sentiment of news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Tabula Rasa HealthCare earned a daily sentiment score of 2.0 on InfoTrie's scale. They also gave news stories about the company a news buzz of 7.0 out of 10, meaning that recent news coverage is likely to have an effect on the company's share price in the near term. View News Stories for Tabula Rasa HealthCare.

Who are some of Tabula Rasa HealthCare's key competitors?

What other stocks do shareholders of Tabula Rasa HealthCare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Tabula Rasa HealthCare investors own include NVIDIA (NVDA), Adobe (ADBE), GW Pharmaceuticals PLC- (GWPH), Micron Technology (MU), Align Technology (ALGN), Netflix (NFLX), QUALCOMM (QCOM), Canopy Growth (CGC), salesforce.com (CRM) and Workday (WDAY).

Who are Tabula Rasa HealthCare's key executives?

Tabula Rasa HealthCare's management team includes the folowing people:
  • Dr. Calvin H. Knowlton, Co-Founder, Chairman & CEO (Age 69)
  • Dr. Orsula V. Knowlton BScPharm, PharmD, MBA, Co-Founder, Pres, Chief Marketing & New Bus. Devel. Officer and Director (Age 50)
  • Mr. Brian W. Adams, CFO & Sec. (Age 37)
  • Mr. Michael Greenhalgh BScPharm, RPh, Chief Operating Officer
  • Ms. Andrea Carolan Speers, Corp. Controller & Chief Accounting Officer (Age 37)

When did Tabula Rasa HealthCare IPO?

(TRHC) raised $60 million in an initial public offering on Thursday, September 29th 2016. The company issued 4,300,000 shares at a price of $13.00-$15.00 per share. Wells Fargo Securities, UBS Investment Bank and Piper Jaffray acted as the underwriters for the IPO and Baird and Stifel were co-managers.

Who are Tabula Rasa HealthCare's major shareholders?

Tabula Rasa HealthCare's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Jennison Associates LLC (4.03%), Artisan Partners Limited Partnership (2.04%), Citigroup Inc. (1.41%), Peregrine Capital Management LLC (1.32%), Braun Stacey Associates Inc. (1.11%) and Emerald Advisers LLC (0.91%). Company insiders that own Tabula Rasa HealthCare stock include Andrea Carolan Speers, Brian W Adams, Bruce Luehrs, Calvin H Knowlton, Gordon Tunstall, Growth Fund 1Q Lp Originate, Orsula V Knowlton and Samira Beckwith. View Institutional Ownership Trends for Tabula Rasa HealthCare.

Which major investors are selling Tabula Rasa HealthCare stock?

TRHC stock was sold by a variety of institutional investors in the last quarter, including SG Americas Securities LLC, Fiera Capital Corp, Braun Stacey Associates Inc., Lido Advisors LLC, New York State Common Retirement Fund, New York State Teachers Retirement System, Oppenheimer Asset Management Inc. and Strs Ohio. Company insiders that have sold Tabula Rasa HealthCare company stock in the last year include Andrea Carolan Speers, Brian W Adams, Calvin H Knowlton, Gordon Tunstall, Orsula V Knowlton and Samira Beckwith. View Insider Buying and Selling for Tabula Rasa HealthCare.

Which major investors are buying Tabula Rasa HealthCare stock?

TRHC stock was acquired by a variety of institutional investors in the last quarter, including Citigroup Inc., Rice Hall James & Associates LLC, Jennison Associates LLC, Pier Capital LLC, Tygh Capital Management Inc., Artisan Partners Limited Partnership, Summit Creek Advisors LLC and BNP Paribas Arbitrage SA. Company insiders that have bought Tabula Rasa HealthCare stock in the last two years include Brian W Adams and Orsula V Knowlton. View Insider Buying and Selling for Tabula Rasa HealthCare.

How do I buy shares of Tabula Rasa HealthCare?

Shares of TRHC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Tabula Rasa HealthCare's stock price today?

One share of TRHC stock can currently be purchased for approximately $49.14.

How big of a company is Tabula Rasa HealthCare?

Tabula Rasa HealthCare has a market capitalization of $1.08 billion and generates $204.27 million in revenue each year. The company earns $-47,270,000.00 in net income (profit) each year or $0.34 on an earnings per share basis. Tabula Rasa HealthCare employs 952 workers across the globe.View Additional Information About Tabula Rasa HealthCare.

What is Tabula Rasa HealthCare's official website?

The official website for Tabula Rasa HealthCare is http://www.tabularasahealthcare.com/.

How can I contact Tabula Rasa HealthCare?

Tabula Rasa HealthCare's mailing address is 228 STRAWBRIDGE DRIVE SUITE 100, MOORESTOWN NJ, 08057. The company can be reached via phone at 866-648-2767 or via email at [email protected]


MarketBeat Community Rating for Tabula Rasa HealthCare (NASDAQ TRHC)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  241 (Vote Outperform)
Underperform Votes:  221 (Vote Underperform)
Total Votes:  462
MarketBeat's community ratings are surveys of what our community members think about Tabula Rasa HealthCare and other stocks. Vote "Outperform" if you believe TRHC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TRHC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/19/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel